Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: UnivDatos Market Insights Pvt Ltd | PRODUCT CODE: 1346801

Cover Image

PUBLISHER: UnivDatos Market Insights Pvt Ltd | PRODUCT CODE: 1346801

Non-Surgical Rhinoplasty Market: Current Analysis and Forecast (2023-2030)

PUBLISHED:
PAGES: 158 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3999
PDF (Site License)
USD 5499
PDF (Global License)
USD 6999

Add to Cart

The global non-surgical rhinoplasty market has experienced significant growth and transformation in recent years, driven by advancements in cosmetic procedures, changing consumer preferences, and an increasing demand for minimally invasive aesthetic enhancements. The non-surgical rhinoplasty market encompasses a range of minimally invasive procedures designed to reshape and enhance the nose's appearance without the need for surgical intervention. These procedures involve injectable dermal fillers and other techniques that offer quick results, reduced downtime, and a more affordable alternative to traditional surgical rhinoplasty.

The Non-Surgical Rhinoplasty Market is expected to grow at a strong CAGR of ~8% during the forecast period. The market has seen a surge in demand as individuals seek non-permanent and less invasive options for nose reshaping. For instance, in the past five years, the number of non-surgical rhinoplasty procedures performed annually has doubled, indicating a significant surge in demand for this minimally invasive cosmetic option. Moreover, Innovations in dermal fillers and application techniques have enhanced the safety, precision, and effectiveness of non-surgical rhinoplasty procedures. New-generation dermal fillers, such as hyaluronic acid-based fillers with varying consistencies, enable practitioners to achieve precise contouring of the nose, enhancing the overall effectiveness and safety of non-surgical rhinoplasty.

Based on filler type, the non-surgical rhinoplasty market is segmented into Hyaluronic Acid (HA) Filler, Calcium Hydroxylapatite (CaHa) Filler, and Others. Amongst these, the HA category is expected to dominate the market during the forecast period from 2023-2030, due to their established track record, broad acceptance, and customizable nature. HA fillers are widely used in various cosmetic procedures due to their natural compatibility with the body and their ability to provide volume and hydration. They are reversible, meaning that if a patient is unsatisfied with the results, the effects can be reversed. HA fillers are popular because they offer versatility and can be tailored to achieve specific results.

By gender, the market is bifurcated into male and female. Among these, female captured the majority share of the Non-Surgical Rhinoplasty market in 2022, as cosmetic procedures have been more widely accepted and integrated into beauty routines among women for years. Non-surgical rhinoplasty offers a way to enhance facial harmony and address cosmetic concerns. Women have historically been more open to cosmetic procedures, and non-surgical rhinoplasty aligns with the broader trend of seeking minimally invasive enhancements.

Based on end users, the market is segmented into dermatology clinics, medical spas, and others. Dermatology clinics will lead the market due to their established reputation for medical credibility and their ability to address a wide range of cosmetic concerns with a focus on patient safety. They are staffed by dermatologists who are highly trained in various cosmetic procedures, including non-surgical rhinoplasty.

For a better understanding of the market adoption of the Non-Surgical Rhinoplasty industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and Rest of World. North America dominated the Non-Surgical Rhinoplasty market in 2022. North America, particularly the United States, has historically been a leader in cosmetic procedures. The United States has a highly developed and advanced medical aesthetics industry, with a significant number of skilled practitioners and well-established cosmetic centers. There has been an increased interest in preventive aesthetics among younger individuals in North America. People in their late 20s and early 30s have shown a trend of seeking non-surgical procedures like non-surgical rhinoplasty as a preventive measure to maintain their youthful appearance. High disposable income, a culture of self-improvement, and advanced medical aesthetics industries have contributed to the popularity of non-surgical rhinoplasty.

Some of the major players operating in the market include: Allergan plc, Galderma S.A., Merz Pharma GmbH & Co. KGaA, Suneva Medical, Teoxane Laboratories, SKINovative of Gilbert-Medical Spa, The London Cosmetic Clinic, Laser Clinic United Kingdom, Nova Aesthetic Clinic, and True MediSpa.

Product Code: UMHE212262

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Non-Surgical Rhinoplasty Market
  • 2.2. Research Methodology of the Non-Surgical Rhinoplasty Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 NON-SURGICAL RHINOPLASTY MARKET REVENUE (USD Mn), 2023F-2030F

6 MARKET INSIGHTS BY FILLER TYPE

  • 6.1. Hyaluronic Acid (HA) Filler
  • 6.2. Calcium Hydroxylapatite (CaHa) Filler
  • 6.3. Others

7 MARKET INSIGHTS BY GENDER

  • 7.1. Male
  • 7.2. Female

8 MARKET INSIGHTS BY END-USERS

  • 8.1. Dermatology Clinics
  • 8.2. Medical Spas
  • 8.3. Others

9 MARKET INSIGHTS BY REGION

  • 9.1. North America
    • 9.1.1. U.S.
    • 9.1.2. Canada
    • 9.1.3. Rest of North America
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. France
    • 9.2.3. U.K.
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Rest of APAC
  • 9.4. Rest of the World

10 NON-SURGICAL RHINOPLASTY MARKET DYNAMICS

  • 10.1. Market Drivers
  • 10.2. Market Challenges
  • 10.3. Impact Analysis

11 NON-SURGICAL RHINOPLASTY MARKET OPPORTUNITIES

12 NON-SURGICAL RHINOPLASTY MARKET TRENDS

13 PRICING ANALYSIS

14 COMPETITIVE SCENARIO

  • 14.1. Competitive Landscape
    • 14.1.1. Porters Fiver Forces Analysis

15 COMPANY PROFILED

  • 15.1. Allergan plc
  • 15.2. Galderma S.A.
  • 15.3. Merz Pharma GmbH & Co. KGaA
  • 15.4. Suneva Medical
  • 15.5. Teoxane Laboratories
  • 15.6. SKINovative of Gilbert-Medical Spa
  • 15.7. The London Cosmetic Clinic
  • 15.8. Laser Clinic United Kingdom
  • 15.9. Nova Aesthetic Clinic
  • 15.10. True MediSpa

16 DISCLAIMER

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!